Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leyvraz

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 25, 2010
An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patientsE Dahmane, T Mercier, B Zanolari, et al.
Bone Marrow Transplantation|November 2, 2004
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working PartyG Rosti, U De Giorgi, H Wandt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiationK Buser, M Bacchi, A Goldhirsch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1992
Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivativeR M Ings, E Lelièvre, C Ardiet, et al.
Cancer|June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment centerR A Joss, K Bürki, P Dalquen, et al.
British Journal of Cancer|November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, C Hürny, M Bacchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detectionN Widmer, A Béguin, B Rochat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trialR Stupp, J Bauer, O Pagani, et al.
British Journal of Cancer|July 1, 1995
Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factorS Leyvraz, N Ketterer, L Perey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, C Hürny, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 25, 2010
An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patientsE Dahmane, T Mercier, B Zanolari, et al.
Bone Marrow Transplantation|November 2, 2004
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working PartyG Rosti, U De Giorgi, H Wandt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiationK Buser, M Bacchi, A Goldhirsch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1992
Value of early pharmacodynamic and pharmacokinetic investigations with anticancer drugs: data from phase I tolerance studies on a new vinca alkaloid derivativeR M Ings, E Lelièvre, C Ardiet, et al.
Cancer|June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment centerR A Joss, K Bürki, P Dalquen, et al.
British Journal of Cancer|November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)J Bernhard, C Hürny, M Bacchi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2004
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detectionN Widmer, A Béguin, B Rochat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trialR Stupp, J Bauer, O Pagani, et al.
British Journal of Cancer|July 1, 1995
Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factorS Leyvraz, N Ketterer, L Perey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, C Hürny, et al.
Pageof 11